Double-blind, Randomized, Placebo-controlled Two-period Crossover Study to Assess the Effect of Levocarnitine on Vismodegib-associated Muscle Spasms
This randomized clinical trial studies levocarnitine in treating patients with vismodegib-associated muscle spasms. Levocarnitine may decrease muscle spasms caused by vismodegib.
Stanford is now accepting new patients for this trial.
- dietary supplement : levocarnitine
- other : questionnaire administration
- other : placebo
Ages Eligible For Study:
- Taking vismodegib daily - Subject answers item #1 of muscle spasms questionnaire as moderate or severe intensity at time of screening - At least one muscle spasm per day at time of screening - Muscle spasms onset after starting vismodegib - Willing and able to understand and sign consent form